Eton Pharmaceuticals (ETON) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eton Pharmaceuticals (ETON) has outperformed Alpha Teknova (TKNO) over the past year, gaining 161.6% versus a gain of 58.9%. Over five years, ETON leads with a +950.9% price change compared with -63.5% for TKNO. Eton Pharmaceuticals is the larger company by market cap ($1.56 billion vs $453.1 million), about 3.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETON | TKNO |
|---|---|---|
| Share price | $54.75 | $8.44 |
| Market cap | $1.56B | $453.13M |
| 1-day change | -0.24% | -3.10% |
| YTD return | +223.77% | +122.11% |
| 1-year return | +161.59% | +58.95% |
| 5-year return | +950.86% | -63.46% |
| P/E ratio (TTM) | 136.88 | — |
| Forward P/E | 21.22 | — |
| EPS (TTM) | $0.40 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $66.37 | $9.48 |
| 52-week low | $14.27 | $1.91 |
| Distance from 52-week high | -17.51% | -10.97% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +29.68% | +6.64% |
| Average volume | 609.36K | 232.69K |
| Shares outstanding | 28.58M | 53.69M |
| Employees | 44 | 158 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eton Pharmaceuticals is about 3.5 times larger than Alpha Teknova by market value ($1.56B vs $453.13M).
- ETON has outperformed TKNO by 102.6 percentage points over the past year.
About Eton Pharmaceuticals
ETON stock →Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.
Healthcare · Drug Manufacturers - Specialty & Generic · 44 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
ETON vs TKNO FAQ
Which is bigger, Eton Pharmaceuticals or Alpha Teknova?
Eton Pharmaceuticals (ETON) is larger, with a market capitalization of $1.56B compared with $453.13M for Alpha Teknova (TKNO).
Which stock has performed better over the past year, ETON or TKNO?
ETON returned +161.59% over the past 12 months, compared with +58.95% for TKNO (price return, excluding dividends). Past performance does not predict future results.
Are Eton Pharmaceuticals and Alpha Teknova in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.